DOA OXY One Step Oxycodone Test with CE certificate urine Test
Device
| Product Name | OXY One Step Oxycodone Test |
| Formats | Strip(3mm)Device(4mm) Multi panel |
| Place of Origen | China |
| Specimen | Urine |
| Read Time | 5 minutes |
| Shelf life | 2 years |
| Package | 25 device/box or 50 strip/Box |
| Storage | 2℃-30℃ |
One Step Oxycodone Test is a rapid one step test for the
qualitative detection of Oxycodone and its principal metabolites in
human urine at specified cut-off level.
For in vitro diagnostic use only. For healthcare professional use only.
INTENDED USE
The One Step Oxycodone Test is a lateral flow chromatographic
immunoassay for the detection of Oxycodone in human urine at the
cut-off concentration of 100 ng/ml. This assay provides only a
qualitative, preliminary analytical test result. A more specific
alternate chemical method must be used in order to obtain a
confirmed analytical result. Gas chromatography/mass spectrometry
(GC/MS) is the preferred confirmatory method. Clinical
consideration and professional judgment should be applied to any
drug of abuse test result, particularly when preliminary positive
results are used.
Device:
- Remove a testing device from the foil pouch by tearing at the notch
and place it on a level surface.
- Holding a sample dropper vertically, add exactly four drops of the
urine specimen to the sample well.
- Read results at 5 minutes. Do not read after 10 minutes.
Strip:
- Remove the test strip from the sealed pouch and use it as soon as
possible.
- With arrows pointing toward the urine specimen, immerse the test strip vertically in the urine specimen for at
least 10-15 seconds. Do not pass the maximum line (MAX) on the test strip when
immersing the strip.
- Place the test strip on a non-absorbent flat surface, start the
timer and wait for the red line(s) to appear.
- The result should be read at 5 minutes. Do not interpret the result after 10 minutes.
SUMMARY
Oxycodone is knwn as Oxycontin, Roxicodone and is an ingredient of
Percodan, Percocet, Roxicet and Tylox. Oxycodone is a
semi-synthetic opiates derived from opium. Like other opiates,
oxycodone is characterized by its analegestic properties, and the
tendency for users to form a physical dependency and develop
tolerance with extended use. Oxycodone is usually administered in
combination with non-opiate analegesics such as acetaminophen and
salicylates for the relief of moderate to severe pain. Oxycodone is
a central nervous system depressant that may cause drowsiness,
dizziness, lethargy, weakness and confusion. Toxicity in an
overdose of oxycodone can lead to stupor, coma, muscle flaccidity,
severe respirator ydepression, hypotension, and cardiac arrest.
Oxycodone is metabolized by N- and O-demethylation. One of the
metabolites, oxymorphone, is a potent narcotic analgesic, while the
other, noroxycodone, is relatively inactive. Between 33 to 61% of a
single dose of oxycodone is excreted in a 24 hour urine collection
and consists of 13-19% free oxycodone, 7-29% glucuronide conjugated
oxycodone, 13-14% glucuronide conjugated oxymorphone and an unknown
amount of noroxycodone. The detection time window of oxycodone is
1-3 days following use.
